Objectives: Pain is a common complication in head and neck cancer. The aim of this paper is to evaluate the evidence from randomised control trials investigating pharmacological and non-pharmacological methods of pain management in head and neck cancer. Material and Methods: Medline, Embase and the Cochrane library databases were searched. Squamous cell carcinomas of the head and neck excluding nasopharyngeal and salivary gland cancers were included. The limits were "human" and "randomised clinical trials". A quality assessment was carried out. Results: 13 studies were included with a total of 644 participants. The primary outcome for most of these papers was pain control post-treatment. Levels of bias varied between the studies. Majority (12 out of the 13 studies) reported intervention to be superior to the control or standard therapy in pain management. Only 46% of the studies were carried out on an intention to treat basis. Two studies reported high dropout rates, with one at 66%. Conclusions: There is insufficient evidence from randomised clinical trials to suggest an optimal pharmacological intervention for head and neck cancer pain post-treatment. Further high quality randomised clinical trials should be conducted to develop an optimal management strategy for head and neck cancer pain.
INTRODUCTION
Head and neck cancer (HNC) is defined as "cancer that arises in the head or neck region (the nasal cavity, sinuses, lips, mouth, salivary glands, throat, or larynx)" [1] . The main histological type is squamous cell carcinoma (SCC) [2] . HNC is more common in men. In 2009 there were over 6000 new HNC diagnoses in the United Kingdom and the incidence is increasing [3] . A geographical variation exists for HNC [4] . Within the United Kingdom, the highest incidence is in Scotland, North of England and Northern Ireland [3] . Major risk factors for HNC are tobacco consumption, heavy alcohol drinking, poor nutrition, specifically low fruit and vegetable consumption and Human Papillomavirus (HPV) [5] [6] [7] . Treatment depends upon the type, staging of the tumour and assessment of co-morbidities [8] [9] . The main treatment options are surgery, radiotherapy, chemotherapy and brachytherapy. Combination therapy has been proven more successful than single modality [10] .The mainstay is surgery and adjuvant radiotherapy [11] . Surgery often results in tissue loss; hence, the use of prosthetics and grafts is necessary to provide a good functional and cosmetic outcome [12] [13] . Pain is defined as "an unpleasant sensation ranging from mild discomfort to agonized distress, associated with real or potential tissue damage" [14] . Scales to measure pain rely on patients reflecting on previous experiences and are therefore unreliable but provide an easy and quick, if subjective, method to gauge pain severity [15] . Examples of pain scales regularly used include: Visual Analogue Scale (VAS), Numerical Rating Scale (NRS), Wong Baker Faces scale, COMFORT scale and Visual Numerical Scale (VNS) [16] [17] [18] [19] [20] . Cancer pain is divided into three categories: tumour induced pain, iatrogenic pain and incidental pain [21] . Tumour induced pain is caused by tissue damage; a consequence of rapid tumour growth, tumour pressure, metastasis or the development of a neuroma. Chemotherapy and radiotherapy result in iatrogenic pain. Incidental pain is caused by any condition present simultaneously with cancer [22] . Pain is a common problem presenting in patients with HNC [23] . A systematic review showed high levels of pain prevalence in HNC patients, particularly before treatment [24] . One study reported pain prevalence being as high as 86% [25] . Pain location and severity in HNC can vary enormously from dysphagia, to pain in the face, neck and ears [2, 26] . Those who have received surgery for their HNC can also develop pain in the shoulder and arm [23, 27] . The WHO has developed a 3-tiered ladder for pain
MATERIAL AND METHODS

Types of studies
This review was conducted following PRISMA statement for reporting systematic reviews [33] . All randomised clinical trials (RCTs) investigating interventions for HNC pain, post-treatment were included.
Types of participants
Human adults (over the age of 18) with primary HNC or metastases to the head and neck were included.
Stage of Cancers
All stages of HNC were included in this paper.
Types of Publications
The following were excluded: Letters, Editorials, Postgraduate thesis, case reports and qualitative studies.
Outcome measures
Pain measured using pain scales such as VAS, NRS, and VNS [16] [17] [18] [19] [20] . Studies, which used patient benefit control [28] , and this guideline is the mainstay for HNC pain management. It states that "if pain occurs, there should be prompt oral administration of drugs in the following order: nonopioids; then, as necessary, mild opioids; then strong opioids such as morphine, until the patient is free of pain. To calm fears and anxiety, adjuvants should be used. To maintain freedom from pain, drugs should be given "by the clock", that is every 3 -6 hours, rather than "on demand". Surgical intervention on appropriate nerves may provide further pain relief if drugs are not wholly effective" [28] . WHO guidelines for pain relief were validated for cancer pain [29] , and specifically for HNC pain. It was shown that the use of analgesic and adjuvant drugs along WHO guidelines to treat pain in HNC is highly effective and relatively safe [30] . However the pain ladder may have limitations in the context of longterm survival [31] . Review of studies which evaluated WHO analgesic ladder in patients with cancer pain showed that there is insufficient evidence for the effectiveness of the WHO guidelines because of lack of the randomised clinical trials [32] . The aim of this paper is to evaluate the evidence from randomised control trials investigating pharmacological and non-pharmacological methods of pain management in head and neck cancer.
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including pain control as an outcome, were also included in this paper.
Literature search methods for identification of studies (Figures 1, 2 or exp postoperative analgesia exp jaw pain or exp neck  pain or exp cancer pain or exp neuropathic pain or exp  chronic pain or exp face pain or exp postoperative pain  or exp pain assessment or exp pain or exp nonsteroid antiinflammatory agent or anti-inflammatory agent exp morphine exp opiate.
References of chosen studies were checked as well as the Cochrane database of systematic reviews [34] . Each search was independently carried out by two authors and all abstracts identified were screened by two or more authors. Full reports were obtained for all studies that were deemed eligible for inclusion in this paper. One paper by Yagi et al. [35] was not available in full text, however, the abstract has been analysed as far as possible.
Data extraction
The following information was extracted: First Author, Year of publication, Study location, Participant information (number, age, gender), Inclusion and Exclusion criteria, Intervention, Comparison group, Duration/follow-up, Method of outcome measurement, dropout rate and results.
Quality assessment
All of the included studies were also subjected to 
Bias Summary (Figure 3)
The Cochrane collaboration bias summary illustrates seven areas of potential bias and was used to assess the quality of studies and identify papers with intrinsic flaws in method and design [37] .
RESULTS
Total of 13 studies were included in this review (Table 1 and Table 2 ). show a higher percentage of patient benefit among the intratumoral cisplatin/epinephrine injectable gel (CDDP/epi gel) group 19% and 34%, compared to the placebo group 9% and 12% respectively. These benefits included pain control, however this difference did not reach statistical significance in either study (P = 0.24 and P = 0.25). Roussier et al. [42] showed that mean VAS pain score at two and six hours after surgery was lower in the epidural Fentanyl group compared to the intravenous (IV) Fentanyl group. Singhal et al. [44] demonstrated that epidural Morphine provided better analgesia than IV Morphine with P < 0.05. Plantevin et al.
[41] investigated the effect of MNB on post-surgical pain, concluding that it was effective in reducing initial postoperative pain 24 hours after surgery. The trial comparing Piroxicam and Acetylsalicylic acid (ASA) conducted by Saxena et al. [43] showed that Piroxicam was a viable alternative to ASA as the first step in the WHO pain ladder for treatment of HNC pain. Wittekindt et al. [46] showed that more patients experienced pain relief in the low dose Botox A group compared to the high dose group. However, there was no significant statistical change in VAS score at baseline or 28 days. Jovic et al. [41] reported that Ketoprofen was superior to Metamizole in controlling post-surgical pain, however this was only statistically significant on day three of treatment (P < 0.05). Cervical epidural Morphine was shown to provide longer lasting analgesia compared to thoracic epidural by Georgiou et al.
[39] while also requiring smaller doses. McNeely et al. [47] reported in 2004 that patients in the PRET group had an overall decrease in pain score of 17% compared to an increase of 1.7% in the control group. In a follow-up study in 2008 the authors reported that overall pain score had a significant larger decrease in the PRET group compared to the current standardized therapeutic exercise protocol (TP) group after adjustment of demographic and medical variables (P = 0.005) [27] . The treatment of pain after neck dissection with acupuncture and usual care was shown to be superior to usual care alone such as analgesics and anti-inflammatory drugs (P < 0.001) by Pfister et al. [48] .
Quality assessment
In Table 3A the methodological quality of the studies was assessed containing randomization, blinding and sample. Furthermore possible bias and the statistical methods used in each study are described in Table 3B . Table 3C shows important information about any side effects of treatment and gives practice implication for each intervention.
Castro et al. 2003 [38]
This double blinded RCT was investigating intratumoural CDDP/epi gel in advanced HNC.
The study had a sample size of 87 patients and low dropout rate of 1 participant make the results more reliable. However the low drop out rate could be due to the fact that the treatment plan was broadly defined. In the blinded phase in which CDDP/epi gel or placebo gel were administered patients could receive a 6 weekly treatments in an 8-week period or less. Only 23% of patients who received CDDP/epi gel completed six treatments and none of the patients who were treated with placebo gel. Also patients got the possibility to cross over in the open label phase after the failure of three treatments in which they received active drug. There was an intentionally increased number of participants in the active group (ratio of 2:1). The reasons for doing this were not stated and could introduce bias. The study had a wide exclusion criterion, which could introduce bias and mean the results cannot be applied to the wider population.
Georgiou et al. 2000 [39]
This RCT had a small sample size of 29 HNC patients. Pain control, with either cervical epidural morphine administration or thoracic epidural morphine technique,
was investigated. Neither a method of randomisation was stated, nor were patients, personnel or assessors blinded. A limitation of this paper is that the administration of analgesia in the community was carried out by a health care professional whose skill set is not adequately described, hence allowing for the possibility of bias. A large number of side effects occurred in this study. More cases of nausea, vomiting and constipation were reported in the intervention group.
Jovic et al. 2008 [40]
This single blinded RCT investigated whether Ketoprofen was superior to Metamizole for relieving postoperative pain following HNC operations. The study had a sample size of 60 patients. The method of randomisation was not stated in the paper leading to a question of bias and the statistical methods used were not described. This trial had no drop out and the aims were clearly stated. The follow-up was stated as being over 3 to 5 days, however, the results only show up to the third day.
McNeely et al. 2004 [47]
This RCT studied the efficacy of PRET in the control of pain after neck dissection surgery as a result of HNC. Subjects within the control arm performed active and passive range of motion (ROM) exercises, which constituted the standard care. This pilot study had a very small sample size (n = 20) reducing the power to draw accurate conclusions. The groups were similar in most respects, except there were more advanced tumour stages included in the exercise group. Analysis was not carried out on an intention to treat basis, which may skew results towards a positive benefit in the exercise group. A major discrepancy included significant variation in the time between surgery and the initiation of the exercise program. Further the study shows an insufficient control of confounders.
McNeely et al. 2008 [27]
This study had a small sample of 52 participants. The planned sample size was 60 participants, so the study was underpowered. Pain and shoulder dysfunction were assessed with the Shoulder Pain and Disability Index (SPADI) questionnaire [49] , which is both valid and reliable method of assessment. Limitations in this study were large variations in time from surgery to intervention and a higher number of subjects with cancer stage 4 in the TP group (72%) than in the PRET group (44%).
Pfister et al. 2010 [48]
A RCT investigating the efficacy of acupuncture in cancer patients with pain after neck dissection. 58 patients participated in this trial which compared acupuncture with physical therapy and analgesics to physical therapies and analgesics alone. 28 subjects were assigned to the acupuncture arm and 30 patients took part as controls. Due to the small sample size, although justified, and the differences between the two treatment groups (e.g. higher proportion of women in acupuncture arm) this trial provides limited evidence for the use of acupuncture. The participant's awareness of the treatment group can potentially influence pain self-assessment.
Plantevin et al. 2007 [41]
This trial was randomized using sealed coded envelopes and double blinded by separating and sedating the patients who received either mandibular nerve block (MNB) or a control subcutaneous (s.c.) injection of normal saline. Both groups also received general anaesthesia (GA). There was a 7% drop out rate from the initial 42 patients, falling short of the calculated justified sample size of 21 subjects in each group. There was no intention to treat. Subjects were required to understand the use of patient controlled analgesia (PCA), excluding patients who might have learning or communication difficulties. The nerve block efficacy could not be evaluated in order to maintain blinding.
Roussier et al. 2006 [42]
This double blind RCT comparing the efficacy of IV versus epidural Fentanyl in the treatment of acute postsurgical pain in HNC patients. The study suffered a drop out rate of 9%, which does not adversely affect conclusions but was not carried out on an intention to treat basis. The patient sample was restricted by all patients being long-time smokers with associated bronchitis. They were required to adequately understand the PCA system before surgery commenced. In clinical practise the epidural technique was found to provide better pain control, however significant risks of the epidural catheterisation resulted in an unfavourable risk benefit ratio.
Saxena et al.1994 [43]
In this trial the randomisation process was not specified, but the blinding process was described as double blind. Double dummy technique where patients in both groups received both the test drug and placebo helped maintain blinding. There was a high dropout rate of 28%, with no mention of a justified sample size, therefore the results may not have adequate power to detect a difference between groups. Both groups were comparable at baseline; however the treatment doses given to the groups were not comparable. A limitation of this study was a short follow-up of only 4 days as ASA and Piroxicam might differ in the short term compared to
the long term use.
Singhal et al. 2006 [44]
This RCT investigated epidural Morphine analgesia compared to IV Morphine for oral surgery with pectoralis major myocutaneous flap (PMMF) reconstruction. The aims were clearly stated and a justified sample size of 60 was calculated and met. 30 patients enrolled in the epidural-and in the IV-morphine group, respectively. A blind observer carried out the pain intensity in each participant using the VAS pain scale.
Werner et al. 2002 [45]
This double blind RCT with clearly stated aims investigated injected epinephrine gel in the local control of cancer pain related to tumour regression. The study was larger than others in the field with 92 participants and met the calculated justified sample size initially; however there was a large dropout (56.1% CDDP/ epi gel group; 82.9% placebo gel group) across the study period resulting in reduced reliability. Pain relief due to the intervention was measured using a patient questionnaire. Results may have been skewed by the variable volume of gel injected, which was anything up to 10 ml depending on patient and tumour tolerance.
Only the most problematic tumours were included. There were a large number of side effects recorded restricting its clinical use to only the most severe cases and in whom all other interventions have been ineffective.
Wittekindt et al. 2006 [46]
This dose-finding study compared the effect of low dose and high dose BtxA in patients with chronic neuropathic pain post neck dissection for HNC. With 23 patients the sample size is small; however it met the calculated sample size. Baseline data of patients was not adequately presented, but the authors claim that the two groups were comparable at baseline. There was no placebo group in this study because the effectiveness of BtxA in post surgery pain treatment of patients with HNC has been reported in prior studies.
Yagi et al. 1997 [35]
A full critical appraisal was not conducted for the paper by Yagi et al. as the full text was not available.
Random sequence generation
All of the studies reviewed used random sequence generation with the exception of Wittekindt et al. [46] . In this paper the authors used a member of the nursing staff to randomly allocate patients with no mention of the method of randomisation being used in this process.
Allocation concealment
McNeely et al. [47] 
Intention to treat basis
Free of selective reporting
Jovic et al.
[40] stopped reporting results after 3 days of follow-up where benefit was seen in the intervention group despite the planned follow period being up to 5 days.
Free of other bias
Three papers were sponsored by the pharmaceutical companies producing the intervention treatment [38, 42, 45] .
DISCUSSION
This systematic review investigated the efficacies of various pain management therapies for HNC patients. There are few RCTs using identical treatments, multiple therapies were reviewed. As pain is unique to the individual, a diverse spectrum of treatments is advantageous when deciding upon analgesia.
There was a wide range of dates and locations of publication for all papers analysed. No study was carried out in the United Kingdom, making any conclusion drawn less applicable to a UK based population. [44] involved participants that were undergoing a radical procedure for oral cancer surgery with PMMF reconstruction. This procedure involves two surgical sites, which give rise to greater postoperative pain than in the study done by Roussier et al. [42] . Hence comparisons between the two trials need to be carefully interpreted, but the conclusion that epidural administration of an analgesic in the short term is more effective than IV administration can be drawn. More complex pain management therapies can be employed such as nerve blocks as demonstrated by the study by Plantevin et al. [41] . The study investigated the efficacy of using Ropivacaine, a local anaesthetic, to block the mandibular nerve. The nerve block reduced the PCA morphine consumption. The authors concluded that it was effective at reducing postoperative pain; however, appropriate anatomical sites for this technique are limited. So for HNC surgery in areas supplied by the mandibular nerve, a nerve block could be effectively employed. It should be noted that MNB is an advanced procedure with a failure rate of 15% to 20%; but based upon the evidence MNB is a viable pain management option when possible [53] [54] . Debulking tumour mass can help to reduce pain as shown in the studies by Werner et al. [45] and Castro et al. [38] . They investigated the response of HNC when subjected to intratumoural CDDP/epi gel. Epinephrine is used in combination with Cisplatin due to its ability to cause vasoconstriction which decreases Cisplatin clearance allowing the cytotoxic agent to act on the tumour cells for longer periods [55] . Both trials used pain control as a secondary outcome. The use of a placebo in both trials is an uncommon feature in pain relief studies due to ethical complications, however, their use increases validity. Patient benefit was analysed in both trials and the following was concluded: injected intratumoural CDDP/epi gel significantly reduces pain in HNC patients. As the procedure is not curative the gel is a palliative option. Further investigation needs to be carried out in order to determine which type of tumours will respond to the gel and how these tumours can be detected, to reduce unnecessary and harmful treatment in patients. Saxena et al. [43] compared the analgesic effects of ASA to Piroxicam in HNC patients in India. Both Aspirin and Piroxicam are NSAIDs with a similar action [56] . It was found that there was no statistically significant difference in the pain relief offered by the two drugs; however, Piroxicam had fewer incidences of side effects. Piroxicam also required fewer and smaller doses throughout the trial, making Piroxicam a superior option for pain relief in HNC patients. The analgesic properties of BtxA were studied by Wittekindt et al. [46] . BtxA is neurotoxin acting on axon terminals. It was found that lower doses of BtxA were more effective at reducing pain than higher doses. The use of lower doses is advantageous as higher doses can cause antibody formation and affect neuromuscular transmission in muscle groups unrelated to the site of pain [57] . The participants in the trial had all undergone a neck dissection, so the use of low doses of BtxA can only be recommended as postoperative analgesia at present. Very few other RCTs have been carried out in this specific field [58, 59] . In all of the trials that were reviewed, sample sizes were relatively small. Furthermore, the research of pain is bound by its idiosyncratic nature and although some trials incorporated objective measurements such as morphine consumption, most involved VAS or patient benefit scoring which has implications on the reliability of the results. It is important that pain scores are comparable within the literature. Pain is highly subjective and different factors (e.g. personal, social, and cultural) may influence the individual report of pain severity. Studies have shown that pain scores judged by professional observers differ from pain scores rated by the patients themselves. Further biases in the measurement of pain could be introduced when the pain intensity is evaluated in an interview by health professionals, especially when the interviewer is personally involved in the care or treatment of the patient. Because of this it is important that studies use reliable and valid instruments and describe the way they were applied [60] . Six studies included in this review used a VAS to measure the severity of pain [35, 39, 41, 42, 44, 46] . A VAS can be presented in many ways but in common it is a horizontal line of which the left end indicates no pain and the right end very severe pain and the patient marks the line at the point they feel representative for their pain condition. VAS is popular in research comparing the effectiveness of analgesic drugs. This pain measurement is highly subjective but it is a good method for displaying the change of pain severity within individuals [61] . However patients need to be trained to use the scale because people do not always easily understand its conception [60] . The Treatments Goal Questionnaire (TGQ) was used in two studies [38, 45] . The TGQ is a validated instrument in HNC patients. Patients and physicians select prospective treatment goals associated with the target tumour and one of eight "palliative" goals (e.g. improve pain control or physical appearance). The physician can chose one of three "preventive" goals (prevention of invasion, obstruction, or subcutaneous tumour from breaking through the skin) instead of the palliative goal. Achievement is met when the goal sustained for at least 28 days. The patient benefit describes the combined goal outcomes of physicians and patients [62, 63] . In the study by Castro et al.
[38] pain control was the most important "palliative" goal selected by physicians and patients which show the high relevance of pain management in HNC patients. In contrast to the VAS a lower sore at the ConstantMurley instrument used by Pfister et al. [48] indicates a poorer outcome. The Constant-Murley-and the SPADI questionnaire are mainly instruments to assess the shoulder function and pain [64] . SPADI, used in the exercise studies by Mc Neely et al. [27, 47] is a valid and reliable instrument but when it is used repeatedly in one patient the minimal detectible change important to the patient is 18 points (MDC 95%) and therefore the results need to be interpreted with caution [65] . Jovic et al.
[40] assessed pain by VNS (0 -10) every 2 hours during the 72 hours. During the night there was a break for six hours in which the nurse stopped interviewing the patients. Other studies measured the pain over different time intervals (e.g. over a 24 hours period, Georgiou et al. [39] or at baseline and after the intervention, Mc Neely et al. [47] . Because of this and other methodological differences between the studies direct comparisons of the pain control interventions should be made with caution. Future studies should present the assessment of pain in more detail explaining the instrument, way of application and time intervals for questioning the patients. This could minimize biases in pain measurement and contribute to higher comparability between studies.
It was shown that a large proportion of cancer patients (nearly one in two) had undertreated cancer pain [66] and suggested that the optimal control of chronic pain in cancer relies on an understanding of the underlying pathophysiology and molecular mechanisms JOURNAL OF ORAL & MAXILLOFACIAL RESEARCH Trotter et al.
involved [31] . Management of cancer pain requires proper pain assessment, availability of oral morphine, co-analgesics and use of advance technology, as well as increasing awareness among clinicians, caregivers and patients [67, 68] .
CONCLUSIONS
The current recommendation to follow is the WHO pain ladder and this recommendation will stand until further studies of a higher standard are conducted.
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This paper investigated a variety of pharmacological and non-pharmacological interventions for the management of head and neck cancer pain post-treatment. There was a variation in the quality of studies and only 2 out of the 13 studies could be directly compared. There is insufficient evidence from randomised clinical trials of head and neck cancer pain to advise on an optimal intervention for head and neck cancer pain. Continuous intravenous infusion of a small dose of Fentanyl or periodical administration of Piroxicam prior to surgery produced better postoperative analgesia after head and neck surgery in comparison to the control group. MNB = mandibular nerve block; VAS = Visual Analogue Scale; PCA = patient controlled analgesia; SPADI = Shoulder Pain and Disability Index; PRET = progressive resistance exercise training; TP = exercise protocol; VNS = Visual Numerical Scale; NRS = Numerical Rating Scale; ASA = acetylsalicylic acid; HN = head and neck; FACT= Functional Assessment of Cancer Therapy Head and Neck ; KPS = Karnofsky Performance Status.
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